상세 보기
ACALABRUTINIB VS IDELALISIB PLUS RITUXIMAB (IDR) OR BENDAMUSTINE PLUS RITUXIMAB (BR) IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF ASCEND
- Ghia, Paolo;
- Pluta, Andrzej;
- Wach, Malgorzata;
- Lysak, Daniel;
- Kozak, Tomas;
- ... Lee, Jae Hoon;
- 외 13명
Citations
WEB OF SCIENCE
0- 제목
- ACALABRUTINIB VS IDELALISIB PLUS RITUXIMAB (IDR) OR BENDAMUSTINE PLUS RITUXIMAB (BR) IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF ASCEND
- 저자
- Ghia, Paolo; Pluta, Andrzej; Wach, Malgorzata; Lysak, Daniel; Kozak, Tomas; Simkovic, Martin; Kaplan, Polina; Kraychok, Iryna; Illes, Arpad; De la Serna, Javier; Dolan, Sean; Campbell, Philip; Musuraca, Gerardo; Jacob, Abraham; Avery, Eric J.; Lee, Jae Hoon; Wang, Denise; Patel, Priti; Jurcza, Wojciech
- 발행일
- 2020-10
- 유형
- Meeting Abstract
- 저널명
- Haematologica
- 권
- 105
- 페이지
- 205 ~ 206
- 언어
- SPA
- 출판사
- FERRATA STORTI FOUNDATION
- 발행국가
- 이탈리아
- 분량
- 2 페이지
- ISSN
- E 1592-8721
P 0390-6078